A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1-Reference-Cited by-同舟云学术

A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1

Published:2015-09-30 Issue:5 Volume:23 Page:434-441
ISSN:2005-4483
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomolecules & Therapeutics

Author:

De Umasankar¹,Kundu Soma²,Patra Nabanita²,Ahn Mee Young³,Ahn Ji Hae¹,Son Ji Yeon¹,Yoon Jung Hyun²,Moon Hyung Ryoung²,Lee Byung Mu¹,Kim Hyung Sik¹

Affiliation:

1. School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea

2. College of Pharmacy, Pusan National University, Busan 609-735, Republic of Korea

3. Department of Oral & Maxillofacial Pathology, College of Dentistry, Wonkwang Bone Regeneration Institute, Daejeon Dental Hospital,Wonkwang University, Daejeon 302-120, Republic of Korea

Funder

National Research Foundation of Korea(NRF)

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2015/023/bt-23-434.pdf

Reference30 articles.

1. The role of histone deacetylases in prostate cancer

2. Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing

3. Management of Cancer of the Prostate

4. Changing views of the role of matrix metalloproteinases in metastasis

5. Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications;Frontiers in Oncology;2024-05-10

2. Therapeutic applications of the prostate cancer epigenome;Epigenetic Cancer Therapy;2023

3. Meclofenamic acid inhibits the invasion and migration of LNCaP prostate carcinoma cells by regulating vimentin expression;Acta Medica Nicomedia;2022-10-15

4. From Therapy Resistance to Targeted Therapies in Prostate Cancer;Frontiers in Oncology;2022-05-24

5. Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer;Cancers;2021-03-08